COCO stock news
This page provides real-time market news, earnings updates, and company announcements related to The Vita Coco Company, Inc. (COCO).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-28 03:07 EST
Dell Technologies (DELL) Announces Financial Results for Fiscal Q4 2026 and Full Year Ended January 30, 2026
Finviz2026-02-28 07:21:04
Baird Cuts PT on Salesforce, Inc. (CRM) to $250 From $315 - Here's Why
Finviz2026-02-28 07:21:04
BofA Lifts PT on Apollo Global Management (APO) to $167 From $161 - Here's Why
Finviz2026-02-28 07:21:05
Wells Fargo Cuts PT on MetLife, Inc. (MET) to $93 From $97, Here's Why
Finviz2026-02-28 07:21:04
Is Blackstone Inc. (BX) One of the Best Cheap Blue Chip Stocks to Buy According to Analysts?
Finviz2026-02-28 07:21:04
Intuit Inc. (INTU) Announces Financial Results for Fiscal Q2 2026
Finviz2026-02-28 07:21:04
Here's What Analysts Are Saying About Vertex Pharmaceuticals (VRTX)
Finviz2026-02-28 07:24:44
Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street?
Finviz2026-02-28 07:24:44
Wolfe Research Initiates Coverage of UniQure (QURE) With a Peer Perform Rating
Finviz2026-02-28 07:24:44
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224
Finviz2026-02-28 07:24:45
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Finviz2026-02-28 07:24:44
Bernstein Lifts PT on BioMarin Pharmaceutical (BMRN) to $94 From $90, Here's Why
Finviz2026-02-28 07:24:44
RBC Capital Maintains a Sector Perform Rating on Beam Therapeutics (BEAM), Here's Why
Finviz2026-02-28 07:24:44
Novo Nordisk A/S (NVO) and Vivtex Corporation Announce a Partnership
Finviz2026-02-28 07:24:44
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Here's What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)
Finviz2026-02-28 07:24:44
Hovnanian's Q1 2026: A High-Risk, High-Reward Play in a Consolidating Sector
101 finance2026-02-28 07:25:01
USA TODAY Co.: Evaluating the Recovery for Investment Portfolio Distribution
101 finance2026-02-28 07:24:50
Carlyle's $200 Billion Ambition: A Turnaround or a Risky Bet?
101 finance2026-02-28 07:33:56
BioMarin's Q4 Beat: A Tale of Priced-In Roctavian Write-Downs vs. Guidance Reset
101 finance2026-02-28 07:42:41
Evaluating Airbnb’s Projected Expansion for 2026: Examining the Viability of Its Blended Approach
101 finance2026-02-28 07:54:38
Rimini Street Q4: Revenue Surpasses Forecasts, Falls Short of Broader Expectations
101 finance2026-02-28 08:01:02
Instacart: A Conviction Buy for Quality Growth Portfolios?
101 finance2026-02-28 08:01:01
Is Blackstone Inc. (BX) One of the Best Cheap Blue Chip Stocks to Buy According to Analysts?
Finviz2026-02-28 07:21:04
Intuit Inc. (INTU) Announces Financial Results for Fiscal Q2 2026
Finviz2026-02-28 07:21:04
Here's What Analysts Are Saying About Vertex Pharmaceuticals (VRTX)
Finviz2026-02-28 07:24:44
Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street?
Finviz2026-02-28 07:24:44
Wolfe Research Initiates Coverage of UniQure (QURE) With a Peer Perform Rating
Finviz2026-02-28 07:24:44
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224
Finviz2026-02-28 07:24:45
Novartis (NVS) Announces Plans to Establish a New Radioligand Therapy Manufacturing Site in Denton, Texas
Finviz2026-02-28 07:24:44
Bernstein Lifts PT on BioMarin Pharmaceutical (BMRN) to $94 From $90, Here's Why
Finviz2026-02-28 07:24:44
RBC Capital Maintains a Sector Perform Rating on Beam Therapeutics (BEAM), Here's Why
Finviz2026-02-28 07:24:44
Novo Nordisk A/S (NVO) and Vivtex Corporation Announce a Partnership
Finviz2026-02-28 07:24:44
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Why Regeneron Pharmaceuticals (REGN) is One of the Top Gene Therapy Stocks to Buy According to Hedge Funds
Finviz2026-02-28 07:24:44
Here's What Analysts Are Saying About CRISPR Therapeutics AG (CRSP)
Finviz2026-02-28 07:24:44
Hovnanian's Q1 2026: A High-Risk, High-Reward Play in a Consolidating Sector
101 finance2026-02-28 07:25:01
USA TODAY Co.: Evaluating the Recovery for Investment Portfolio Distribution
101 finance2026-02-28 07:24:50
Carlyle's $200 Billion Ambition: A Turnaround or a Risky Bet?
101 finance2026-02-28 07:33:56
BioMarin's Q4 Beat: A Tale of Priced-In Roctavian Write-Downs vs. Guidance Reset
101 finance2026-02-28 07:42:41
Evaluating Airbnb’s Projected Expansion for 2026: Examining the Viability of Its Blended Approach
101 finance2026-02-28 07:54:38
Rimini Street Q4: Revenue Surpasses Forecasts, Falls Short of Broader Expectations
101 finance2026-02-28 08:01:02
Instacart: A Conviction Buy for Quality Growth Portfolios?
101 finance2026-02-28 08:01:01
COCO stock chart
COCO stock detailsCOCO stock price change
On the last trading day, COCO stock closed at 57.41 USD, with a price change of 4.25% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more